The payment and amount of dividends will be decided by the board of Fisher & Paykel Healthcare Corporation Limited (“Fisher & Paykel Healthcare”). It is the current intention of the directors of Fisher & Paykel Healthcare to distribute dividends in accordance with the following dividend policy:
The directors have established a target debt to debt plus equity ratio in the range of +5% to -5% (excluding unrealised financial instrument gains or losses) to support business growth and operation of its foreign currency hedging policy. The company expects that a dividend pay-out ratio of approximately 70% of net profit after tax will be appropriate to achieve and maintain that target gearing.
Dividends will be paid in the period following that to which they relate, with the dividend payout dates being December and July of each year.
To the extent they are available, it is the intention of the board to attach imputation credits to dividends.
The payment and amount of any future dividends will be at the discretion of the board after taking into account various factors the board deems relevant. These factors may include Fisher & Paykel Healthcare's financial condition, operating results, current and anticipated cash needs, plans for expansion and debt covenants.
Under the imputation regime, New Zealand tax paid gives rise to imputation credits that can be attached to dividends paid to shareholders. New Zealand tax resident shareholders can offset these imputation credits to reduce their income tax liability in respect of that dividend. The amount of the dividend and the imputation credits (together the "gross" dividend) must be included in a New Zealand tax resident shareholder's income tax return. Resident withholding tax will be deducted from a dividend at a rate of 33% to the extent that imputation credits attached to the dividend do not cover the full 33% tax due on the gross dividend.
If a shareholder has a certificate of exemption from resident withholding tax this should be provided to Fisher & Paykel Healthcare's share registry, Link Market Services Limited.
Non-resident shareholders receiving dividends will generally be subject to non-resident withholding tax. Fisher & Paykel Healthcare generally expects to pay supplementary dividends to non-resident shareholders pursuant to the foreign investor tax credit regime to reduce or eliminate the economic impact of statutory withholding taxes for those non-residents.
Dividends are paid in New Zealand and Australian currency.
Find clinical evidence and practice guidelines for delivering nasal high flow (aka HFNC) therapy.
Providing Optimal Humidity for intubated patients
Featuring under nose NIV masks (F&P Visairo) and full face NIV masks - (F&P Nivairo), with vented and non-vented options to suit your hospital NIV mask needs.
Establish effective spontaneous breathing or assist ventilation of the lungs
Respiratory support that replaces spontaneous breathing
Noninvasive respiratory support that provides a continuous distending pressure
Noninvasive respiratory support that delivers high flows of blended air and oxygen
Designed to work in harmony with the way patients naturally breathe while they sleep
F&P SleepStyle - designed to strike the balance between comfort and effective treatment